Avid Bioservices Inc (CDMO)

[sulaco]

Chenzo, we sat at $1.34 for MONTHS

Try to look at the big picture. Citibank (which has soared incredibly over the past year by the way), sees immunotherapy, specifically Mabs, as a $35 BILLION market in the near future. Bigger than statins (Lipitor!).

Now who has the most exciting Mab out there right now? Yeah, that's right, the one in your portfolio, and it starts with a "P" and ends with an "M."

AAPL was once $10 pps. Last year it hit $700 (although it has since retraced obviously).

Let the story play itself out. "Forget" about Bavi for a little while. Then return. Soon enough, you'll be pleasantly shocked.


Best,

Joe